FDA grants clearance for Sorrento Phase II/III Covid-19 therapy trial
Sorrento Therapeutics has obtained the US FDA clearance to initiate the Phase II/III trial of Abivertinib in hospitalised Covid-19 patients.
Stay updated with breaking news from Based Software Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sorrento Therapeutics has obtained the US FDA clearance to initiate the Phase II/III trial of Abivertinib in hospitalised Covid-19 patients.
On Rare Disease Day, Clinical Trials Arena highlights news stories you need to catch up on. Featuring stories on ALS and Huntington's disease.
Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalDataâs Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, ...
Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalDataâs Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, ...
Pfizer has announced that the company will not commence any new clinical trials in Russia amid the Ukraine crisis.